{
    "nct_id": "NCT00104442",
    "title": "Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2007-12-17",
    "description_brief": "Alzheimer's disease is a medical illness that damages the brain and causes problems with memory, mood and behavior. A substance called acetylcholine (ACh), which is naturally produced in the body, plays an important role in the normal functioning of the brain. In subjects with Alzheimer's disease, the level of ACh is greatly reduced. Currently, there are three commonly prescribed drugs used for treating the symptoms of Alzheimer's disease by helping to maintain the level of ACh in the brain. This study will evaluate how much each of these drugs changes the levels of certain brain chemicals that are known to, or may play an important role in, Alzheimer's disease and its symptoms.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE4"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": null,
    "target_category": "cognitive enhancer",
    "drug": [
        "donepezil",
        "rivastigmine",
        "galantamine"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The trial description says it will evaluate \"three commonly prescribed drugs\" that help maintain acetylcholine (ACh) levels in people with Alzheimer's disease. Drugs that preserve ACh work by inhibiting acetylcholinesterase and are used to treat cognitive symptoms (memory, thinking) rather than to remove pathology like amyloid or tau. \ue200cite\ue202turn0search0\ue202turn0search7\ue201",
        "Act (extraction and evidence): The three commonly prescribed acetylcholine-preserving drugs in clinical use are donepezil (Aricept), rivastigmine (Exelon) and galantamine (Razadyne). These are acetylcholinesterase (cholinesterase) inhibitors \u2014 small-molecule therapies that increase synaptic ACh and are indicated to improve or stabilize cognitive symptoms in Alzheimer\u2019s disease. \ue200cite\ue202turn0search0\ue202turn0search1\ue202turn0search3\ue201",
        "Act (matching to category): Based on the mechanism (increasing acetylcholine to treat cognitive symptoms) and drug type (small-molecule cholinesterase inhibitors), the trial fits the \"cognitive enhancer\" category: symptomatic cognitive improvement without being a biologic aimed at core AD pathology. \ue200cite\ue202turn0search7\ue201",
        "Reflect: I verified that these three drugs are repeatedly listed in authoritative sources as the commonly prescribed acetylcholinesterase inhibitors; they are not biologics or targeted disease-modifying small molecules (e.g., anti-amyloid/tau agents). Therefore classifying this study as investigating cognitive enhancers is consistent with the description and the cited sources. \ue200cite\ue202turn0search2\ue202turn0search5\ue201",
        "Web search results used: Mayo Clinic overview of cholinesterase inhibitors listing donepezil, galantamine, rivastigmine. \ue200cite\ue202turn0search0\ue201",
        "Web search results used: Alzheimer's-focused sources and drug pages summarizing Exelon (rivastigmine), Razadyne (galantamine), and Aricept (donepezil). \ue200cite\ue202turn0search1\ue202turn0search5\ue201",
        "Web search results used: Reviews and evidence summaries (PubMed/NCBI and Cochrane) noting the three drugs as acetylcholinesterase inhibitors used to treat cognitive symptoms in AD. \ue200cite\ue202turn0search2\ue202turn0search7\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial evaluates three commonly prescribed drugs (donepezil, rivastigmine, galantamine) that act to preserve acetylcholine (ACh) levels by inhibiting acetylcholinesterase, i.e., they modulate cholinergic neurotransmission rather than targeting core AD pathology (amyloid/tau). \ue200cite\ue202turn0search0\ue202turn1search2\ue201",
        "Act (extraction and evidence): Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor that increases synaptic ACh. \ue200cite\ue202turn1search2\ue202turn1search6\ue201 Rivastigmine is a carbamate (pseudo\u2011irreversible) inhibitor of AChE and butyrylcholinesterase that increases cholinergic signalling. \ue200cite\ue202turn0search6\ue201 Galantamine is an acetylcholinesterase inhibitor (with reported additional nicotinic receptor modulatory actions in some studies) that increases ACh availability. \ue200cite\ue202turn0search2\ue202turn0search3\ue201",
        "Act (mapping to CADRO): These mechanisms act on the cholinergic neurotransmitter system (modulating neurotransmitter levels/receptor signalling), so the CA D R O category that best matches is D) Neurotransmitter Receptors (symptomatic cognitive enhancement via cholinergic modulation). \ue200cite\ue202turn0search0\ue201",
        "Reflect: The drugs are symptomatic cognitive enhancers that increase acetylcholine availability and are not primarily disease\u2011modifying agents targeting amyloid, tau, inflammation, or other core pathologies \u2014 so D) Neurotransmitter Receptors is the most specific CADRO category. If the trial explicitly targeted nicotinic receptor subtypes (e.g., a selective nAChR agonist) the classification could still fall under D; because these are cholinesterase inhibitors (and one has reported nAChR modulation), D remains correct. \ue200cite\ue202turn1search2\ue202turn0search2\ue201",
        "Web search results used (sources): Mayo Clinic overview: cholinesterase inhibitors (lists donepezil, rivastigmine, galantamine). \ue200cite\ue202turn0search0\ue201; Donepezil mechanism and prescribing information/reviews (Aricept label; review/StatPearls). \ue200cite\ue202turn1search6\ue202turn1search2\ue201; Rivastigmine review describing carbamate pseudo\u2011irreversible AChE/BuChE inhibition. \ue200cite\ue202turn0search6\ue201; Galantamine descriptions including AChE inhibition and reported nicotinic modulation (DrugBank and supporting publications). \ue200cite\ue202turn0search2\ue202turn0search3\ue201"
    ]
}